The national incidence and clinical picture of SLE in children in Australia - a report from the Australian Paediatric Surveillance Unit

被引:21
作者
Mackie, F. E. [1 ,2 ]
Kainer, G. [1 ,2 ]
Adib, N. [3 ]
Boros, C. [4 ,5 ]
Elliott, E. J. [6 ]
Fahy, R. [7 ]
Munro, J. [8 ]
Murray, K. [9 ]
Rosenberg, A. [1 ,2 ]
Wainstein, B. [10 ]
Ziegler, J. B. [10 ]
Singh-Grewal, D. [11 ]
机构
[1] Sydney Childrens Hosp, Dept Nephrol, Randwick, NSW 2031, Australia
[2] Univ NSW, Sydney, NSW, Australia
[3] Queensland Paediat Rheumatol Serv, Adelaide, SA, Australia
[4] Univ Adelaide, Discipline Paediat, Adelaide, SA, Australia
[5] Women & Childrens Hlth Network, Adelaide, SA, Australia
[6] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia
[7] Alice Springs Hosp, Dept Paediat, Alice Springs, NT, Australia
[8] Royal Childrens Hosp, Rheumatol Unit, Melbourne, Vic, Australia
[9] Princess Margaret Hosp Children, Perth, WA, Australia
[10] Sydney Childrens Hosp, Dept Immunol, Randwick, NSW 2031, Australia
[11] Sydney Childrens Hosp Network, Dept Rheumatol, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
Systemic lupus erythematosus; incidence; Australian Aboriginal and Torres Strait Islanders; lupus nephritis; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYCOPHENOLATE-MOFETIL; RHEUMATIC-DISEASES; INDUCTION TREATMENT; LONG-TERM; NEPHRITIS; ONSET; HYDROXYCHLOROQUINE; PREVALENCE; ABORIGINES;
D O I
10.1177/0961203314552118
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The objectives of this paper are to prospectively determine the incidence of paediatric systemic lupus erythematosus (pSLE) in Australia as well as describe the demographics, clinical presentation and one-year outcome. Study design Newly diagnosed cases of pSLE were ascertained prospectively from October 2009 to October 2011 through the Australian Paediatric Surveillance Unit (a national monthly surveillance scheme for notification of childhood rare diseases) as well as national subspecialty groups. Questionnaires were sent to notifying physicians at presentation and at one year. Results The annual incidence rate was 0.32 per 10(5) children aged less than 16 years. The incidence was significantly higher in children of Asian or Australian Aboriginal and Torres Strait Islander parents. Approximately one-third of children underwent a renal biopsy at presentation and 7% required dialysis initially although only one child had end-stage kidney disease (ESKD) at one-year follow-up. Conclusion The incidence of pSLE in Australia is comparable to that worldwide with a significantly higher incidence seen in children of Asian and Australian Aboriginal and Torres Strait Islander backgrounds. Renal involvement is common but progression to ESKD, at least in the short term, is rare.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 52 条
  • [1] Anstey N, 1993, AUST NZ J MED, V23, P645
  • [2] Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
    Appel, Gerald B.
    Contreras, Gabriel
    Dooley, Mary Anne
    Ginzler, Ellen M.
    Isenberg, David
    Jayne, David
    Li, Lei-Shi
    Mysler, Eduardo
    Sanchez-Guerrero, Jorge
    Solomons, Neil
    Wofsy, David
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (05): : 1103 - 1112
  • [3] Australian Bureau of Statistics, 2010, 3235 POP AG SEX REG
  • [4] CLINICAL-FEATURES OF SYSTEMIC LUPUS-ERYTHEMATOSUS - DIFFERENCES RELATED TO RACE AND AGE OF ONSET
    BALLOU, SP
    KHAN, MA
    KUSHNER, I
    [J]. ARTHRITIS AND RHEUMATISM, 1982, 25 (01): : 55 - 60
  • [5] Baqi N, 1996, J AM SOC NEPHROL, V7, P924
  • [6] Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
    Bertsias, George K.
    Tektonidou, Maria
    Amoura, Zahir
    Aringer, Martin
    Bajema, Ingeborg
    Berden, Jo H. M.
    Boletis, John
    Cervera, Ricard
    Doerner, Thomas
    Doria, Andrea
    Ferrario, Franco
    Floege, Juergen
    Houssiau, Frederic A.
    Ioannidis, John P. A.
    Isenberg, David A.
    Kallenberg, Cees G. M.
    Lightstone, Liz
    Marks, Stephen D.
    Martini, Alberto
    Moroni, Gabriela
    Neumann, Irmgard
    Praga, Manuel
    Schneider, Matthias
    Starra, Argyre
    Tesar, Vladimir
    Vasconcelos, Carlos
    van Vollenhoven, Ronald F.
    Zakharova, Helena
    Haubitz, Marion
    Gordon, Caroline
    Jayne, David
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1771 - 1782
  • [7] BLOOR G, 1982, AUST NZ J MED, V12, P553
  • [8] Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis
    Chan, TM
    Tse, KC
    Tang, CSO
    Mok, MY
    Li, FK
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04): : 1076 - 1084
  • [9] CHRISTIANSEN FT, 1991, J RHEUMATOL, V18, P1350
  • [10] Council of Australian Governments, 2010, COAG REF CONC HLTH C